Insider buying
~$7.6K10K sh @ $0.762
Their first buy on recordTraded Dec 30, 2025 · filed 153 days later
Since the trade −64.8% · S&P 500 +9.8% · to Nov 13
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CJMB · NASDAQ · Services-Business Services, Nec
Callan Jmb (CJMB) · oqro.io/stocks/CJMB · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.4084+0.0313 (+8.30%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
No open-market purchase by an insider of Callan Jmb was filed in the last 90 days. The latest on record was on Jun 1, 2026.
Since 2025, Callan Jmb insiders reported 18 open-market purchases and 0 sales on Forms 4 and 5, with purchases in 2 different years, most recently 2026.
No open-market sale by an insider of Callan Jmb (CJMB) was filed with the SEC in the last 90 days.
No trade in Callan Jmb (CJMB) was disclosed by a member of Congress in the last 12 months.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
−88.1% (−$3.03) from Nov 13, 2025 to Nov 13, 2026 · adjusted daily closes
Adjusted close went from $3.44 on Nov 13, 2025 to $0.4084 on Nov 13, 2026 (−88.1%). Disclosed in this range: 13 insider trades, 0 pre-arranged insider sales, 0 Congress trades.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Services-Business Services, Nec company based in Spring Branch, Tx.
Last 12 months
−88.1%
Market value
$2.35M
S&P 500 +12.3% over the same dates. Prices adjusted for splits and dividends.
Short interest: 204K shares sold short (3.5% of shares outstanding), +104.5% vs the previous count, 1.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$1.38M
−17.4% vs the same quarter a year earlier
Free cash flow, last 12 months
−$4.74M
This quarter −$430K, a year earlier −$996K
Net debt
—
Debt —, cash $860K, at Jun 30, 2026
Net income, last 12 months
−$9.77M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Mar 31, 2026.
Revenue, fiscal 2025
$5.72M
−12.8% vs the year before
Net income, fiscal 2025
−$7.97M
A loss for the year
Shares outstanding
5.75M
As of Aug 12, 2026
In fiscal 2024 the company spent $3.33M on dividends. Cash actually paid, from its cash-flow statement.
Insider buying
Their first buy on recordTraded Dec 30, 2025 · filed 153 days later
Since the trade −64.8% · S&P 500 +9.8% · to Nov 13
Insider buying
11 days before resultsTraded Mar 20 · filed 6 days later
Since the trade −79.1% · S&P 500 +16.3% · to Nov 13
Callan Jmb's Chief Medical Officer paid $18K out of pocket for Callan Jmb shares.
Insider buying
Traded Mar 6 · filed 4 days later
Since the trade −77.3% · S&P 500 +12.2% · to Nov 13
Callan Jmb's Chief Medical Officer paid $26K out of pocket for Callan Jmb shares.
Traded Dec 30, 2025 · largest single transaction ~$1.8K
Dec 30, 2025~$1.8K · 1,539 sh @ $1.20
DetailsOfficial recordDec 30, 2025~$562 · 461 sh @ $1.22
DetailsOfficial recordPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Callan Jmb reported 18 open-market purchases and 0 sales since 2025; purchases in 2 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $44K2×2 trades | — |
| 2025 | $584K16×16 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Notice of delisting or failure to meet listing rules
8-K on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govNotice of delisting or failure to meet listing rules
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.